Pune, India — 12/20/2017 — The Global Image Guided Radiotherapy Market report titled “Image Guided Radiotherapy Market Research Report-Forecast to 2023? is a specialist investigation report by Market Research Future includes broad essential research alongside the definite examination of subjective and additionally quantitative perspectives by different industry specialists, key sentiment pioneers to pick up a more profound understanding of the market and industry execution.
Market Research Future published new report, titled “Image Guided Radiotherapy Market -Research Report: Global Forecast to 2023”.
TOSHIBA CORPORATION (Japan), ViewRay (US), Hitachi, Ltd. (Japan), Siemens AG (Germany), General Electric Company (US), Varian Medical Systems, Inc. (US), Vision RT Ltd. (UK), C-RAD (Sweden) Scranton Gillette Communications (US), XinRay Systems (US), and Koninklijke Philips N.V. (Netherland) are some of the prominent players at the forefront of competition in the Global Imaging Guided Radiotherapy Market and are profiled in MRFR Analysis.
Global Image Guided Radiotherapy Market – Overview:
The Global Imaging Guided Radiotherapy (IGRT) Market is growing exponentially owing to the rising prevalence of cancer and growing demand for advanced therapies are the major factor driving the Imaging Guided Radiotherapy Market. The global IGRT market is expected to grow at a CAGR of 15.8% during the forecasted period.
According to WHO, the number of patients who are presently living after a cancer diagnosis has increased compared to the past when cancer biological therapies was not available or less practiced in the healthcare industry. As per WHO the average healing rate for the US in 2013 was 196.1 in males for all ages the global rate for cancer survivors is also increasing, this number of cancer survivals has improved since the innovation of cancer biological therapies and this factor will continue to assist the growth of the cancer biological therapies market.
At the molecular level, cancer is a genetic disease that develops due to mutation of genes in somatic cells. The growing rates of different types of cancers calls for new and advanced treatments options. These developing therapies for cancer will have huge demand, as cancer is the 2nd largest reason for deaths in the world (as per WHO).
Global Image Guided Radiotherapy Market – Industry Updates:
Nov, 2017 ViewRay, Inc. has successfully installed the MR-Guided Radiotherapy System in Washington University. This initiative is expected to increase the customer base for ViewRay Inc. and strengthen its position in USA.
Nov, 2017 ViewRay, Inc. has successfully installed the MRIdian® Linac in Rigshospitalet and Herlev Hospitals, Denmark. This initiative is expected to strengthen its market in Europe.
Dec, 2017 Varian's Halcyon Treatment System, an image guided radiotherapy has recently received ANVISA Registration from Brazil. With this approval Varian has expanded its reach in Latin America and has the opportunities to increase the overall customer base.
June, 2016 Merck to acquire afferent pharmaceuticals in a deal where Merck will acquire a privately held afferent pharmaceutical's. Afferent pharmaceuticals is a leader in the development of therapeutic, thus this acquisition will benefit Merck and strengthen their therapeutic segment.
GET SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/4276 .
Global Imaging Guided Radiotherapy Market – Regional Analysis
According to regions, the global Imaging Guided Radiotherapy Market is dominated by North America. The factor contributing for its growth includes the rising medical tourism and increasing healthcare sector privatization in this region. According to National Institute of Health (NIH) it has been found that in 2016, a projected 1,685,210 new cases of cancer will be detected in the United States and 595,690 individuals will die from the disease which further increases the growth of the market.
Moreover the prevalence of chronic disease is increasingly spreading in North American countries, For example according to survey of National Center for Chronic Disease Prevention and Health Promotion (CDC) in United States every year 7 out of 10 individuals die due to chronic diseases and 86% of healthcare costs in the country. With cancer biological therapy playing a primary role for patients treatment and enhancing the market for North America region.
In 2014, European Society for Medical Oncology estimated the cost burden of cancer and estimated around 110 to 120 billion euros. Germany accounted for approximately 20% to 26% of total cost. As per the Associations of European Cancer League, 3 million new cancer cases occur in 38 European countries. Breast cancer and prostate cancer has been diagnosed within one third of European population. Many European cancer organizations including cancer Immunology & Immunotherapy Center (CIIC) are strategizing collaborations with developing countries in Europe with the aim to improve diagnosis and therapeutic treatment for different types of cancer, particularly including prostate and breast cancer for Europe
Asia-Pacific market is expect to be the fastest growing market. This high growth is mainly attributed due to increasing R&D funding by the developing countries like China and India for the development of healthcare sector. The various others factors that influence the growth of the market include growing incidence of cancer, aging population, Increasing demand for advanced therapies, patent expiry of leading drugs, government initiatives and increasing public awareness about various diseases and treatment options.
Global Image Guided Radiotherapy market has been segmented on the basis of treatment types which comprises of invasive, non-invasive and minimal invasive. On the basis of procedure include Arm lift, Breast lift, Stomach lift and Lower body lift.
MAJOR TABLE OF CONTENTS:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
Chapter 3. Research Methodology
Chapter 4. Market Dynamics
Chapter 5. Market Factor Analysis
Chapter 6. Global Image Guided Radiotherapy Market, By Types
Chapter 7. Global Image Guided Radiotherapy Market, By Technology
Chapter 8. Global Image Guided Radiotherapy Market, By Devices
Chapter 9. Global Image Guided Radiotherapy Market, By End Users
Chapter 10. Global Image Guided Radiotherapy Market By Region
Chapter 11. Company Landscape
Chapter 12. Company Profiles
Chapter 13. MRFR Conclusion
GET DISCOUNT @ https://www.marketresearchfuture.com/check-discount/4276 .
About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312
Email: [email protected]
Latest posts by Brad Bennett (see all)
- PAYDAY 2â„¢ now available on the Nintendo Switchâ„¢ System in Europe and Australia - February 23, 2018
- Discover Your Market Potential with CHD Expertâ€™s New Landscape on the Hotel Industry - February 23, 2018
- Virginia Sollars, Author Of 'And Some Will Triumph', Believes On-Line Dating Sites Are Often Used By Sociopaths, Scammers And Anti-Social Predators - February 23, 2018